SEC Filings - Prelude Therapeutics

Filing Date	Description	Form	View
September 16, 2020	Amended Registration statement for face-amount certificate companies	S-1/A	0001193125-20-246920.pdf 0001193125-20-246920.rtf 0001193125-20-246920.xls View HTML
September 16, 2020	Registration of certain classes of securities 12(b) of the Securities Exchange Act	8-A12B	0001193125-20-246935.pdf 0001193125-20-246935.rtf 0001193125-20-246935.xls View HTML
September 16, 2020	CORRESP	CORRESP	0001193125-20-246931.pdf 0001193125-20-246931.rtf 0001193125-20-246931.xls View HTML
September 9, 2020	CORRESP	CORRESP	0001193125-20-242105.pdf 0001193125-20-242105.rtf 0001193125-20-242105.xls View HTML
September 8, 2020	UPLOAD	UPLOAD	0000000000-20-008397.pdf 0000000000-20-008397.rtf View HTML
September 4, 2020	Registration statement for face-amount certificate companies	S-1	0001193125-20-240138.pdf 0001193125-20-240138.rtf 0001193125-20-240138.xls View HTML
August 28, 2020	Form D	D	0001678660-20-000001.pdf 0001678660-20-000001.rtf 0001678660-20-000001.xls View HTML
August 26, 2020	Amendment to a previously filed DRS	DRS/A	0000950123-20-009357.pdf 0000950123-20-009357.rtf 0000950123-20-009357.xls View HTML
August 19, 2020	UPLOAD	UPLOAD	0000000000-20-007661.pdf 0000000000-20-007661.rtf View HTML
July 23, 2020	Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy	DRS	0000950123-20-007154.pdf 0000950123-20-007154.rtf 0000950123-20-007154.xls View HTML

Data provided by Kaleidoscope.